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S U M M A R Y
Objectives: To assess the different types of antibiotic-taking behavior and to compare self-reported with
objectively measured adherence to antibiotic regimens in respiratory infections.
Methods: This was a prospective study of patients with suspected bacterial pharyngitis and lower
respiratory tract infections recruited from ﬁve primary care clinics in Catalonia. Adherence to various
antibiotic regimens was assessed by the Medication Event Monitoring System (MEMS), which recorded
every opening of the patient’s bottle of tablets, and a self-reported adherence question. The outcome
variables were antibiotic-taking adherence, correct dosing, and timing adherence.
Results: A total of 428 patients were included in the analysis. Five types of antibiotic use behavior were
observed: excellent adherence (130 patients, 30.4%), acceptable adherence over time (53; 12.4%),
declining adherence over time (123; 28.7%), non-adherence to correct dosing (108; 25.2%), and
unacceptable adherence (14; 3.3%). Excellent adherence was signiﬁcantly associated with the number of
daily doses of antibiotic and antibiotic duration. A total of 254 patients reported never forgetting to take
the antibiotic (59.3%), achieving a negative predictive value of 100% and a positive predictive value of
51.2%.
Conclusions: Outpatients with respiratory infections treated with antibiotics showed poor adherence
outcomes. Self-reported adherence was remarkably higher than that observed with the use of MEMS and
failed to predict true patient adherence.
 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Medical adherence is deﬁned as the extent to which a patient’s
taking of medication is consistent with medical or health advice.1
Non-adherence to medications is particularly important in clinical
practice. Adherence to medications has long been a concern
because it often affects the outcome of treatment. In a review of 63
studies over a 30-year period, the authors reported that if the
patient is adherent, the odds of a good outcome are almost three-
fold higher than for those who are non-adherent.2 In the case of
infectious diseases, non-adherence to antibiotics might also lead to
the storing of antibiotics at home, which induces self-medication,
leading to a vicious circle, and thereby favoring the emergence of
bacterial resistance.3
Measuring adherence is difﬁcult because most of the direct and
indirect measures available have limitations. Since their introduc-
tion in 1986, microelectronic devices have become the gold* Corresponding author. Tel.: +34 977247211; fax: +34 977248459.
E-mail address: carles.llor@urv.cat (C. Llor).
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http://dx.doi.org/10.1016/j.ijid.2012.09.012standard in adherence research.4 The most commonly used system
is the Medication Event Monitoring System (MEMS). MEMS
medication bottles contain a microelectronic chip that registers
the date and time of opening of every bottle. Assuming that the
opening of a bottle represents the intake of medication, MEMS
provides a detailed proﬁle of the patient’s adherence behavior. For
this reason, MEMS is currently regarded as the gold standard for
the measurement of adherence.5–7 MEMS have been used to
monitor adherence mainly with long-term medications, and in the
case of infectious diseases, this technology has particularly been
used to track medication adherence with antiretroviral agents and
with anti-tuberculosis drugs. However, data on the antibiotic-
taking behavior in respiratory tract infections in the community
are lacking.7 With the use of MEMS we previously observed that
adherence to antibiotic regimens in respiratory infections de-
creased with an increase in the number of daily doses.8
Simple questions are the most commonly used measures of
treatment adherence in medical consultation. The simplest
question is asking if the patient has taken the treatment as
requested. Physicians assume that patients provide honest
answers and we usually believe their responses. However,ses. Published by Elsevier Ltd. All rights reserved.
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adherence behavior.9 The use of a non-judgmental, non-threat-
ening approach is therefore recommended, preceding the
question with a remark such as the following: ‘‘People often
have difﬁculty taking their pills for one reason or another’’, before
asking if the patient has missed any dose.10 The use of this
approach decreases the overestimation of true adherence in
chronic disorders, but the beneﬁt of this in acute conditions such
as respiratory tracts infections remains unanswered. In the
current study we aimed to assess the different types of antibiotic
use behavior among patients with respiratory tract infections and
to compare the performance of a self-reported adherence
question with objectively measured adherence of antibiotic
regimens in these infections.
2. Methods
We performed a prospective, observational study in ﬁve
general medicine outpatient clinics from 2003 to 2008 in
Catalonia, Spain. We recruited patients aged 18 years or older
presenting to the primary care practice with uncomplicated,
acute (<7 days), suspected bacterial pharyngitis and lower
respiratory tract infections. We excluded patients who had
received previous treatment with antibiotics, those who pre-
sented criteria for hospitalization, those with any condition
requiring the aid of other persons for drug administration, and
those with hypersensitivity to antibiotics. The patients were
treated with different antibiotic regimens previously included in
the MEMS (Aardex Group Ltd, Zug, Switzerland) containers. The
physicians decided which of these antibiotic treatments was to
be administered.
Before the initiation of the study, the Spanish health authorities
were informed about its characteristics and how it was to be
conducted. Spanish legislation at the time of the study determined
that institutional review board approval was not required for
observational studies. However, the patients gave informed
consent to participate in a study on the rational use of antibiotics.
They were provided with complete information about the
characteristics of the study and their participation, but were not
informed at that time about the future assessment of adherence to
avoid bias in the results. When they returned to the clinic, the
physician collected the MEMS container and self-reported adher-
ence was evaluated by means of the following question: ‘‘We
almost always forget to take all of the pills, did you ever forget to
take any?’’ Patients were fully informed about the results, and
permission was requested to include these data anonymously in
the current report. All the data included in the database were
encoded to ensure conﬁdentiality. The data contained in the
microprocessors were transferred to the computer and processed
with PowerView program v. 1.3.2. (Aardex Ltd). Multiple openings
of the container within a period of less than 15 min were not
counted.
2.1. Adherence parameters
Three different outcome measures were taken into account: (1)
‘Taking adherence’, calculated as the percentage of times the
container was opened during the course of the treatment, related
to the total number of pills included in the container. Good taking
adherence was considered when it was greater than 80%. (2)
‘Correct dosing’, calculated as the number of days on which the
patient opened the container at least the prescribed number of
times, that is, at least three times for those assigned to the three
times-daily antibiotics, twice for patients treated with twice-daily
regimens, and once for those receiving once-daily antibiotic
courses. For twice- and three times-daily regimens, dosing on day 1may be restricted due to the late start of treatment (after visiting
the physician), and this has to be taken into account. Good correct
dosing was considered when it was greater than 80%. (3) ‘Timing
adherence’, indicating whether the opening of the container
coincided with the times recommended: intervals of 8+4 h during
at least 80% of the three times-daily courses of antibiotics, 12+6 h
intervals during at least 80% of the antibiotic course for the twice-
daily antibiotics, and 24+12 h intervals during at least 80% of the
antibiotic course for the once-daily antibiotics.
Excellent adherence was deﬁned when these three adherence
outcomes were good.
2.2. Statistical analysis
Descriptive statistics were used to describe the different
adherence parameters observed in this study. We used Chi-square
tests to compare proportions. The sensitivity, speciﬁcity, and
positive and negative predictive values of the self-reported
adherence question were determined with a two-way contingency
table, using the adherence parameters provided by MEMS as the
gold standard. A logistic regression model was constructed to
identify variables signiﬁcantly and independently associated with
excellent adherence. The variables were included in the model if
they were associated with a high score with a p-value of <0.10.
Variables were eliminated from the model using the stepwise
automatic variable screening method, the alpha thresholds for
inclusion and exclusion being set at 0.20. Statistical signiﬁcance
was accepted at p < 0.05.
3. Results
A total of 481 patients were recruited. The self-reported
adherence question was not registered for 37 patients. Further-
more, seven antibiotic treatment failures were observed requiring
a change in antimicrobial treatment, and the adherence question
was not evaluated in these cases. Seven patients did not return the
MEMS container and two more refused to give consent (Figure 1).
Of the 428 patients with complete information available for
analysis, 236 (55.1%) received antibiotics three times daily, 151
received twice-daily antibiotic regimens, and the remaining 41
patients received once-daily antibiotic schedules. The different
antibiotics used are described in Figure 1. A total of 251 patients
(58.6%) were diagnosed with a lower respiratory tract infection
and the remaining 177 patients were diagnosed with suspected
bacterial pharyngitis. The mean age of all the patients was of
47.1  21.2 years, and 231 were females (54.0%).
A total of 265 patients opened the vial at least 80% of the times
(61.9%), 146 presented correct dosing adherence (34.1%), and 165
achieved good timing adherence for at least 80% of the antibiotic
course (38.6%). Five patterns of antibiotic taking behavior were
observed in this study: 130 patients (30.4%) achieved 80% of all the
adherence outcomes and therefore presented excellent adherence.
Another 53 patients (12.4%) missed only one dose for achieving
excellent adherence and presented a relatively acceptable adher-
ence during the antibiotic course. A total of 123 patients (28.7%)
presented declining adherence over time with good correct dosing
at the beginning of the antibiotic course followed by a reduction in
the daily doses along the remainder of the course until the end.
Thirteen of these patients (10.6%) abruptly stopped taking the
tablets in the ﬁrst half of the medication course. A total of 108
patients (25.2%) presented non-adherence to consistent correct
dosing over time and 14 (3.3%) presented an unacceptable
adherence pattern, with incorrect dosing and a further decline.
The adherence parameters were consistently worse with three
times-daily antibiotic regimens and better with once-daily courses
(p < 0.001) (Table 1).
a
Patients were recommended to  take two  tablets every 12 hours
481 Eligible pae nts
(203 pharyngis and 278 LRTI)
428 Pae nts included in the anal ysis
(177 pharyngis and 251 LRTI)
37 Pae nts were n ot  asked about  their adhe rence
7 Pae nts  failed and the anbi oc  was chan ged; they were n ot  asked
7 Pae nts did not  return the MEMS  contain er
2 Pae nts  refu sed  to  give i nform ed  con sent  at the  foll ow-up  vi sit
41 Once-da ily anbi oc  regimens :
• 17 Levoﬂoxacin 500 mg 10 tablets
• 12 Azith romycin 5 00 mg  3 tablets
• 9 Moxiﬂoxacin 400 mg 7 tablets
• 3 Moxiﬂoxacin 400 mg 5 tablets
151 Twice-da ily anbioc  regimens :
• 57 Am oxi cillin /cl avulanate 
1000 /125 mg 28 tabletsa
• 73 Phenoxymethylpenicillin 400 mg 
30 tabletsa
• 15 Cefdi toren 200 mg 20  tablets
• 6 Cefu roxime acetyl 500 mg  20 
tablets 
236 Th ree mes-da ily  anbi oc  reg imens
• 12 9 Am oxi cillin /cl avulanate 50 0/125 mg 
24 table ts
107 Amoxicillin 500 mg 24 tablets•
Figure 1. Flow of patients through the study.
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analysis were the patient characteristics (age, gender, presence of
high blood pressure, dyslipidemia, or diabetes mellitus, smoking
status, and retired or not) and antibiotic-related variables (daily
doses, duration, and presence of adverse effects). Excellent
adherence was signiﬁcantly associated with the number of daily
doses of the antibiotic (odds ratio (OR) 0.22, 95% conﬁdence
interval (CI) 0.15–0.32) and antibiotic duration (OR 0.77, 95% CI
0.61–0.96).
A total of 254 patients answered the self-reported adherence
question (good self-reported adherence) negatively (59.3%). The
remaining patients answered either afﬁrmatively or elicited an
unclear response. A total of 304 patients were correctly identiﬁed
by this approach (71.0%). All patients presenting excellent
adherence by means of the MEMS determination reported never
forgetting to take their medications. On the other hand, the answer
was negative in only 124 of the 298 patients who did not present
excellent adherence (41.6%). As shown in Table 2, the negative
predictive value of the question was 100%, with a positive
predictive value of 51.2%. Table 3 describes the different responses
depending on the type of antibiotic used.
4. Discussion
This study compared self-reporting with objectively measured
medication adherence using an evidence-based cut-off point in the
same study population. The main result of this study is that
medication adherence objectively measured by MEMS was veryTable 1
Types of antibiotic-taking behavior depending on the number of daily doses in the ant
Once-daily antibiotic
regimen
Excellent adherence 34 (82.9) 
Acceptable adherence over time 5 (12.2) 
Declining adherence over time 2 (4.9) 
Non-adherence to consistent correct dosing 0 (0) 
Unacceptable adherence 0 (0) 
Total 41 poor since only 30% of the patients presented excellent adherence.
Furthermore, the use of self-reported adherence remarkably
overestimated the true adherence.
Five adherence types were identiﬁed in this study by means of
the MEMS method: excellent adherence, relatively consistent
adherence over time deﬁned as those patients who missed only
one dose for achieving excellent adherence, declining adherence
over time, non-adherence to correct dosing, and unacceptable
adherence. In a qualitative semi-structured interview study of 46
people, Hawkings et al.11 reported six different types of antibiotic
user behavior: those who always took antibiotics as prescribed,
could not take doses because of work, child care, or social
constraints, frequently forgot doses, believed it made sense to
stop taking antibiotics as they started to get better, actively sought
to limit antibiotic use because they believed their own bodies
became used to them or because antibiotics are unnatural, and
deliberately planned to stop early so as to have an antibiotic
supply for self-use in the future to avoid the challenges of
consulting and obtaining antibiotics in primary care. In the
Hawkings study, over a third of the respondents reported that
they always took antibiotics as directed by the clinician or
pharmacist. The results of the present study clearly indicate that
less than a third of the patients took the tablets as requested. We
used the same cut-off point recommended by the previous
authors, i.e., at least 80% of all the adherence parameters
evaluated.12 However, only a little more than 12% of the patients
nearly achieved these goals since they only missed one dose, and
in all these cases the patients stated that they were adherent byibiotic regimen
Twice-daily
antibiotic regimen
Three times-daily
antibiotic regimen
Total
77 (51.0) 19 (8.1) 130 (30.4)
23 (15.2) 25 (10.6) 53 (12.4)
34 (22.5) 87 (36.8) 123 (28.7)
16 (10.6) 92 (39.0) 108 (25.2)
1 (0.7) 13 (5.5) 14 (3.3)
151 236 428
Table 2
Validity of the self-reported adherence question
Response to the self-reported adherence questiona True adherence Total
Excellent Not excellent
Negative response (good self-reported adherence) 130 124 254
Afﬁrmative or unclear response (not good self-reported adherence) 0 174 174
Total 130 298 428
a We almost always forget to take all of the pills, did you ever forget to take any?
Sensitivity: 130/130 = 100%; speciﬁcity: 174/298 = 58.4%; positive predictive value: 130/254 = 51.2%; negative predictive value: 174/174 = 100%.
Table 3
Response to the self-reported adherence question depending on the antibiotic-taking behavior
Antibiotic-taking behavior Response to the self-reported adherence questiona Total
Negative response Afﬁrmative or unclear response
Excellent adherence 130 (100) 0 (0) 130
Acceptable adherence over time 53 (100) 0 (0) 53
Declining adherence over time 47 (38.2) 76 (61.8) 123
Non-adherence to consistently correct dosing 23 (19.8) 85 (78.7) 108
Unacceptable adherence 1 (7.1) 13 (92.9) 14
Total 254 (59.3) 174 (40.7) 428
a We almost always forget to take all the pills, did you ever forget to take any?
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strates that the rationale for choosing a cut-off of 80% to deﬁne
adherence in order to differentiate between adherence and non-
adherence is arbitrarily chosen, and despite commonly being used
by health professionals, it is not shared by patients who have to
take the medication.
In our study, more than half of the patients with non-adherence
to consistently correct dosing and declining adherence over
time admitted to have forgotten some doses. Incorrect dosing is
more linked to unintentional non-adherence, since it is inﬂuenced
by the constraints of work, child care, school, and simply
forgetting, while declining adherence over time is more associated
with intentional non-adherence, and it is more likely that these
patients are not aware of the consequences of stopping early.
Despite being unintentional, patients who systematically forgot to
take a pill every day were more aware of being non-adherent than
those who had a priori intentional non-adherence, since nearly 80%
of the former respondents admitted having forgotten to take some
doses vs. 60% of the latter who did so. Patients who stopped taking
antibiotics as they started to get better, those who limited their use
because of some misbeliefs, and those who planned to have an
antibiotic supply at home are supposed to have excellent
adherence at the beginning of treatment and a deteriorating
adherence after some days, but curiously only 10% of these patients
stopped the treatment too soon. The remaining 90% of these
patients actually decreased the frequency of the doses after a
period of perfect adherence. This probably means that most of the
patients with declining adherence over time were aware that
taking the antibiotics was necessary and felt guilty about stopping
to take them.
The number of adherence types is likely to vary with the study
population under analysis. In studies involving long-term condi-
tions, other typologies of medication use behavior have been
detected, such as improving adherence over time. For example,
Knaﬂ et al.13 identiﬁed 10 adherence types for subjects with HIV on
antiretroviral medications, including seven relatively consistent,
one deteriorating, and two improving adherence types. However,
with treatment lengths of up to 10 days, such as the schedule
addressed in our study, the number of medication use behaviors is
much lower, with three typologies being the most common – one
of good adherence and two basic patterns of non-adherence. We
only included outpatients with relatively benign acute conditionsand this fact might explain why so many patients failed to present
excellent adherence behavior.
Another conclusion of this study is that medication adherence
measured by the self-reported adherence question was remark-
ably higher than that objectively measured by MEMS, indicating
that self-reporting seems to be prone to overestimating of true
adherence. To our knowledge this is the ﬁrst time that a self-
reported question has been used to report the adherence of
patients in acute infectious diseases. The main explanation that
may underlie the difference between self-reported and ‘true’
adherence is that patients may not want to admit that they are
non-adherent, and therefore reported adherence. Self-reported
adherence is able to detect non-adherence when the patient
reports forgetting some doses, since a patient who admits not
having forgotten any dose can be either adherent or non-adherent
with respect to timing and dosing. Therefore this screening
question has little value in clinical practice.
There were some limitations to this study. The adherence data
analyzed were collected electronically using MEMS caps. Cap
openings do not always necessarily correspond to actual medica-
tion-taking. Patients may sometimes have removed multiple doses
at one cap opening in order to put them in pill boxes, in which case
the cap openings underestimate actual adherence. Moreover,
multiple openings of the container within a period of less than
15 min were not counted. Neither can we ensure that when
phenoxymethylpenicillin and the new pharmacokinetically en-
hanced formulation of amoxicillin/clavulanate were administered,
the patients took two tablets at the same time. The diagnosis was
clinical and therefore it cannot be guaranteed that all the episodes
included were actually bacterial infections; however this could
have happened equally in all the treatment regimens and should
not be directly related to the adherence to treatment. Nonetheless,
we believe that the electronic method used in this study, the large
sample studied, and the fact that the patients were not informed as
to the real objective of the study until the second visit,
undoubtedly constitute the greatest strengths of this study.
In conclusion, less than half of the patients treated with regular
courses of antibiotics presented excellent or acceptable adherence.
Approximately one in four patients presented non-adherence to
correct dosing and approximately one in four presented declining
adherence over time. The adherence outcomes were consistently
and signiﬁcantly worse with three times-daily antibiotic schedules
C. Llor et al. / International Journal of Infectious Diseases 17 (2013) e168–e172e172and better with once-daily antibiotic regimens. The self-reported
adherence question presented a signiﬁcant negative predictive
value but its low positive predictive value makes this method
inappropriate for use in clinical practice.
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